These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 25455877)

  • 1. Assessment of treatment response using PET.
    Basu S; Kumar R; Ranade R
    PET Clin; 2015 Jan; 10(1):9-26. PubMed ID: 25455877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An update on novel quantitative techniques in the context of evolving whole-body PET imaging.
    Houshmand S; Salavati A; Hess S; Werner TJ; Alavi A; Zaidi H
    PET Clin; 2015 Jan; 10(1):45-58. PubMed ID: 25455879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of EORTC criteria and PERCIST for PET/CT response evaluation of patients with metastatic colorectal cancer treated with irinotecan and cetuximab.
    Skougaard K; Nielsen D; Jensen BV; Hendel HW
    J Nucl Med; 2013 Jul; 54(7):1026-31. PubMed ID: 23572497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection and characterization of tumor changes in 18F-FDG PET patient monitoring using parametric imaging.
    Necib H; Garcia C; Wagner A; Vanderlinden B; Emonts P; Hendlisz A; Flamen P; Buvat I
    J Nucl Med; 2011 Mar; 52(3):354-61. PubMed ID: 21345787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From RECIST to PERCIST: Evolving Considerations for PET response criteria in solid tumors.
    Wahl RL; Jacene H; Kasamon Y; Lodge MA
    J Nucl Med; 2009 May; 50 Suppl 1(Suppl 1):122S-50S. PubMed ID: 19403881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating tumor response with FDG PET: updates on PERCIST, comparison with EORTC criteria and clues to future developments.
    Pinker K; Riedl C; Weber WA
    Eur J Nucl Med Mol Imaging; 2017 Aug; 44(Suppl 1):55-66. PubMed ID: 28361188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular imaging (PET) of brain tumors.
    Basu S; Alavi A
    Neuroimaging Clin N Am; 2009 Nov; 19(4):625-46. PubMed ID: 19959009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification in clinical fluorodeoxyglucose positron emission tomography.
    Hallett WA
    Nucl Med Commun; 2004 Jul; 25(7):647-50. PubMed ID: 15208490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positron emission tomography/computed tomography: the current technology and applications.
    Mittra E; Quon A
    Radiol Clin North Am; 2009 Jan; 47(1):147-60. PubMed ID: 19195540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Standards for PET image acquisition and quantitative data analysis.
    Boellaard R
    J Nucl Med; 2009 May; 50 Suppl 1():11S-20S. PubMed ID: 19380405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Practical PERCIST: A Simplified Guide to PET Response Criteria in Solid Tumors 1.0.
    O JH; Lodge MA; Wahl RL
    Radiology; 2016 Aug; 280(2):576-84. PubMed ID: 26909647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical evaluation of PET image reconstruction using a spatial resolution model.
    Andersen FL; Klausen TL; Loft A; Beyer T; Holm S
    Eur J Radiol; 2013 May; 82(5):862-9. PubMed ID: 23254158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of fast-RAMLA in clinical PET.
    Sato H; Cho K; Fukushima Y; Shiiba M; Hakozaki K; Kiriyama T; Sakurai M; Kanaya K; Kumita S
    Ann Nucl Med; 2008 Dec; 22(10):869-76. PubMed ID: 19142705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of tumour response with (18)F-fluorodeoxyglucose positron emission tomography using three-dimensional measures compared to SUVmax--a phantom study.
    Boucek JA; Francis RJ; Jones CG; Khan N; Turlach BA; Green AJ
    Phys Med Biol; 2008 Aug; 53(16):4213-30. PubMed ID: 18653927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Molecular imaging in oncological surgery: technical principles and importance].
    Kotzerke J
    Chirurg; 2014 Jun; 85(6):474-80. PubMed ID: 24805798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parametric imaging: a promising approach for the evaluation of dynamic PET-18F-FDG studies - the DKFZ experience.
    Dimitrakopoulou-Strauss A; Pan L; Strauss LG
    Hell J Nucl Med; 2010; 13(1):18-22. PubMed ID: 20411165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regarding "Segmentation of heterogeneous or small FDG PET positive tissue based on a 3D-locally adaptive random walk algorithm" By DP. Onoma et al.
    Hatt M; Visvikis D
    Comput Med Imaging Graph; 2015 Dec; 46 Pt 3():300-1. PubMed ID: 26494613
    [No Abstract]   [Full Text] [Related]  

  • 18. PET/CT in oncology--a major advance.
    Wechalekar K; Sharma B; Cook G
    Clin Radiol; 2005 Nov; 60(11):1143-55. PubMed ID: 16223611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular positron emission tomography and PET/CT imaging in urological malignancies.
    Powles T; Murray I; Brock C; Oliver T; Avril N
    Eur Urol; 2007 Jun; 51(6):1511-20; discussion 1520-1. PubMed ID: 17275167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ¹⁸F-fluorodeoxyglucose PET/computed tomography for primary brain tumors.
    Segtnan EA; Hess S; Grupe P; Høilund-Carlsen PF
    PET Clin; 2015 Jan; 10(1):59-73. PubMed ID: 25455880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.